Deep Track Capital’s Kura Oncology KURA Stock Holding History

Deep Track Capital’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.7M	Sell	1,978,565 -664,977	-25%	-$6.27M	0.32%	55
2026 Q1	$21.5M	Buy	+2,643,542	New	+$22.7M	0.35%	51
2024 Q4	–	Sell	-1,963,505	Closed	-$38.4M	–	72
2024 Q3	$38.4M	Buy	1,963,505 +1,578,749	+410%	+$32M	1.22%	29
2024 Q2	$7.92M	Buy	+384,756	New	+$7.91M	0.24%	53
2022 Q4	–	Sell	-3,186,083	Closed	-$43.5M	–	68
2022 Q3	$43.5M	Sell	3,186,083 -511,886	-14%	-$7.9M	1.99%	15
2022 Q2	$67.8M	Buy	3,697,969 +285,969	+8%	+$4.11M	4.46%	6
2022 Q1	$54.9M	Buy	3,412,000 +862,000	+34%	+$12.4M	3.52%	11
2021 Q4	$35.7M	Buy	+2,550,000	New	+$41.3M	2.52%	15

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Deep Track Capital's KURA Position: Q2 2026 in Review

Deep Track Capital reduced its Kura Oncology (KURA) stake by 25% in Q2 2026, selling an estimated $6.27M and leaving 1,978,565 shares worth $21.7M. The position accounts for 0.32% of the portfolio, ranked #55.

Deep Track Capital first reported a position in KURA in Q4 2021 and has held it in 8 quarters since. The position peaked at $67.8M in Q2 2022. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

Deep Track Capital held 1,978,565 shares of Kura Oncology worth $21.7M as of Q2 2026.
Deep Track Capital sold 664,977 Kura Oncology shares in Q2 2026, an estimated $6.27M.
Kura Oncology made up 0.32% of Deep Track Capital's portfolio in Q2 2026, its #55 holding.
Deep Track Capital first reported a position in Kura Oncology in Q4 2021 and has held it in 8 quarters since.
Deep Track Capital's Kura Oncology position peaked at $67.8M in Q2 2022.
220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.